Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Emery

Showing results (1-10 of 731) with videos related to

Pageof 74
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|December 12, 2003
Role of adalimumab, a novel TNF antagonist in advancing rheumatoid arthritis controlPaul Emery
Drugs of Today (Barcelona, Spain : 1998)|May 11, 2005
Adalimumab therapy: clinical findings and implications for integration into clinical guidelines for rheumatoid arthritisPaul Emery
Current Opinion in Rheumatology|March 6, 2016
Introduction: the future of rheumatoid arthritis managementPaul Emery
Rheumatology (Oxford, England)|June 22, 2012
Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatmentPaul Emery
Arthritis Research|July 12, 2002
Magnetic resonance imaging: opportunities for rheumatoid arthritis disease assessment and monitoring long-term treatment outcomesPaul Emery
Nature Reviews. Rheumatology|April 2, 2011
Rheumatoid arthritis: International disparities in access to anti-TNF therapyPaul Emery
Pharmacoeconomics|May 26, 2004
Review of health economics modelling in rheumatoid arthritisPaul Emery
Nature Reviews. Rheumatology|December 24, 2014
Rheumatoid arthritis in 2014: Exciting times for RA researchPaul Emery
Arthritis Research & Therapy|August 29, 2014
Why is there persistent disease despite biologic therapy? Importance of early interventionPaul Emery
BMJ (Clinical Research Ed.)|January 21, 2006
Treatment of rheumatoid arthritisPaul Emery
Pageof 74

Showing results (1-10 of 731) with videos related to

Sort By:
Pageof 74
Drugs of Today (Barcelona, Spain : 1998)|December 12, 2003
Role of adalimumab, a novel TNF antagonist in advancing rheumatoid arthritis controlPaul Emery
Drugs of Today (Barcelona, Spain : 1998)|May 11, 2005
Adalimumab therapy: clinical findings and implications for integration into clinical guidelines for rheumatoid arthritisPaul Emery
Current Opinion in Rheumatology|March 6, 2016
Introduction: the future of rheumatoid arthritis managementPaul Emery
Rheumatology (Oxford, England)|June 22, 2012
Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatmentPaul Emery
Arthritis Research|July 12, 2002
Magnetic resonance imaging: opportunities for rheumatoid arthritis disease assessment and monitoring long-term treatment outcomesPaul Emery
Nature Reviews. Rheumatology|April 2, 2011
Rheumatoid arthritis: International disparities in access to anti-TNF therapyPaul Emery
Pharmacoeconomics|May 26, 2004
Review of health economics modelling in rheumatoid arthritisPaul Emery
Nature Reviews. Rheumatology|December 24, 2014
Rheumatoid arthritis in 2014: Exciting times for RA researchPaul Emery
Arthritis Research & Therapy|August 29, 2014
Why is there persistent disease despite biologic therapy? Importance of early interventionPaul Emery
BMJ (Clinical Research Ed.)|January 21, 2006
Treatment of rheumatoid arthritisPaul Emery
Pageof 74